FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT

MDR report key: 2863483 · Received December 10, 2012

Report

Report Number
3007111389-2012-00251
Event Type
Malfunction
Date Received
December 10, 2012
Date of Event
November 7, 2012
Report Date
December 7, 2012
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
MMI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONFIRMED THAT A NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROP I ES PATIENT RESULT WAS OBTAINED WHILE USING THE VITROS 3600 SYSTEM. THERE IS NO EVIDENCE THAT AN INSTRUMENT RELATED AND/OR A REAGENT RELATED ISSUE CONTRIBUTING TO THE EVENT. ADDITIONALLY, THE SAMPLE WAS NOT PROCESSED IN ACCORDANCE WITH THE TUBE MANUFACTURER'S RECOMMENDATIONS. IT IS LIKELY THAT CELLULAR DEBRIS, DUE TO POOR SAMPLE PREPARATION, WAS PRESENT IN THE AFFECTED SAMPLE, ALTHOUGH THIS COULD NOT BE CONFIRMED. THE INVESTIGATION COULD NOT DETERMINE A DEFINITIVE ROOT CAUSE. HOWEVER, A PRE-ANALYTICAL SAMPLE PROCESSING ISSUE CANNOT BE RULED OUT AS A CONTRIBUTING FACTOR.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED A NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROP I ES RESULT (0.747 VS. AN EXPECTED RESULT <0.012 NG/ML ) FROM A SINGLE PATIENT SAMPLE PROCESSED ON THE VITROS 3600 SYSTEM. THE HIGHER THAN EXPECTED PATIENT RESULT WAS REPORTED FROM THE LABORATORY. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION. HOWEVER, THE SAMPLE WAS RETESTED AS THE NURSE QUESTIONED THE HIGHER THAN EXPECTED RESULT. A CORRECTED REPORT WAS ISSUED. THERE WAS NO ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT IN-VITRO DIAGNOSTIC MMI ORTHO-CLINICAL DIAGNOSTICS 1030

Patients

Seq Age Sex Outcome Treatment
1